| 1. |
- Wolpin, Brian M., et al.
(författare)
-
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
- 2014
-
Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 46:9, s. 994-
-
Tidskriftsartikel (refereegranskat)abstract
- We performed a multistage genome-wide association study including 7,683 individuals with pancreatic cancer and 14,397 controls of European descent. Four new loci reached genome-wide significance: rs6971499 at 7q32.3 (LINC-PINT, per-allele odds ratio (OR) = 0.79, 95% confidence interval (CI) 0.74-0.84, P = 3.0 x 10(-12)), rs7190458 at 16q23.1 (BCAR1/CTRB1/CTRB2, OR = 1.46, 95% CI 1.30-1.65, P = 1.1 x 10(-10)), rs9581943 at 13q12.2 (PDX1, OR = 1.15, 95% CI 1.10-1.20, P = 2.4 x 10(-9)) and rs16986825 at 22q12.1 (ZNRF3, OR = 1.18, 95% CI 1.12-1.25, P = 1.2 x 10(-8)). We identified an independent signal in exon 2 of TERT at the established region 5p15.33 (rs2736098, OR = 0.80, 95% CI 0.76-0.85, P = 9.8 x 10(-14)). We also identified a locus at 8q24.21 (rs1561927, P = 1.3 x 10(-7)) that approached genome-wide significance located 455 kb telomeric of PVT1. Our study identified multiple new susceptibility alleles for pancreatic cancer that are worthy of follow-up studies.
|
|
| 2. |
- Billnert, Robert, 1981, et al.
(författare)
-
New information on the characteristics of 1 in. x 1 in. cerium bromide scintillation detectors
- 2011
-
Ingår i: Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. - : Elsevier BV. - 0168-9002 .- 1872-9576. ; 647:1, s. 94-99
-
Tidskriftsartikel (refereegranskat)abstract
- In view of highly demanded new and accurate data on prompt gamma-ray emission in nuclear fission a major part of investigations is directed towards the selection of suitable detector systems. Here we have studied a new type of crystal scintillation detectors made from cerium bromide (CeBr(3)). For the first time a full characterization of such a detector is presented in terms of energy resolution, pulse-height linearity, intrinsic activity and intrinsic timing resolution. In particular the latter one is very important for prompt fission gamma-ray studies, because the presence of fast neutrons, emitted in fission too, requires the time-of-flight method for their discrimination. The energy resolution has been found to be comparable to that of cerium-doped LaCl(3):Ce detectors at an efficiency comparable to the one of a LaBr(3):Ce detector of the same size. The intrinsic activity of the CeBr(3) crystal was observed to be much lower compared to lanthanum halide crystals. The intrinsic timing resolution of a coaxial 1 in. x 1 in. sized detector was measured relative to that of a previously characterized LaCl(3):Ce detector and found to be (326 +/- 7) Ps at (60)Co energies, which is in between those of a LaBr(3):Ce and a LaCl(3):Ce detector of same size.
|
|
| 3. |
- Billnert, Robert, 1981, et al.
(författare)
-
Novel Scintillation Detectors for Prompt Fission γ-Ray Measurements
- 2012
-
Ingår i: Physics Procedia. - : Elsevier BV. - 1875-3884 .- 1875-3892. ; 31, s. 29-34
-
Konferensbidrag (refereegranskat)abstract
- In this work we present first results from measurements of prompt fission γ-rays from the spontaneous fission in 252Cf. New and accurate data on corresponding γ-rays from the reactions 235U(nth,f) and 239Pu(nth,f) are highly demanded for the modeling of new Generation-IV nuclear reactor systems. For these experiments we employed scintillation detectors made out of new materials (LaBr3, LaCl3 and CeBr3), whose properties were necessary to know in order to obtain reliable results. Hence, we have characterized these detectors. In all the important properties these detectors outshine sodium-iodine detectors that where used in the 1970s, when the existing data had been acquired. Our finding is that the new generation of scintillation detectors is indeed promising, as far as an improved precision of the demanded data is concerned.
|
|
| 4. |
|
|
| 5. |
- Lutter, G., et al.
(författare)
-
Radiopurity of a CeBr3 crystal used as scintillation detector
- 2013
-
Ingår i: Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. - : Elsevier BV. - 0168-9002. ; 703, s. 158-162
-
Tidskriftsartikel (refereegranskat)abstract
- Cerium bromide (CeBr3) has recently been shown to exhibit several properties making it a suitable material as a scintillation detector in nuclear physics applications. The intrinsic activity of gamma-ray emitting radionuclides in a 38.1 mm x 38.1 mm (diameter x height) crystal of CeBr3 was investigated. The measurements were carried out in the HADES underground laboratory located 225 m underground. Two primordial radionuclides were detected; Ac-227 (and its daughters) with massic activity of 0.30 +/- 0.02 Bq/kg and La-138 with massic activity of 7.4 +/- 1.0 mBq/kg. Two activation products were also detected; Ce-139 and Br-82. Their massic activities (assuming a homogeneous distribution in the crystal) just before taking the CeBr3 crystal underground were 4.3 +/- 0.3 mBq/kg and 18 +/- 4 mBq/kg correspondingly. None of the other common primordial radionuclides (K-49, Ra-226, Ra-228, Th-228, and U-235) were detected and their detection limits were below 2 mBq/kg except for U-238 for which the upper limit was 135 mBq/kg and Pb-210 with an upper limit of 600 mBq/kg.
|
|
| 6. |
- Nordestgaard, B. G., et al.
(författare)
-
Lipoprotein(a) as a Cardiovascular Risk Factor: Current Status
- 2010
-
Ingår i: European Heart Journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 31:23, s. 2844-2853
-
Tidskriftsartikel (refereegranskat)abstract
- Aims The aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on desirable levels, and on therapeutic strategies. Methods and results The robust and specific association between elevated Lp(a) levels and increased cardiovascular disease (CVD)/coronary heart disease (CHD) risk, together with recent genetic findings, indicates that elevated Lp(a), like elevated LDL-cholesterol, is causally related to premature CVD/CHD. The association is continuous without a threshold or dependence on LDL- or non-HDL-cholesterol levels. Mechanistically, elevated Lp(a) levels may either induce a prothrombotic/anti-fibrinolytic effect as apolipoprotein(a) resembles both plasminogen and plasmin but has no fibrinolytic activity, or may accelerate atherosclerosis because, like LDL, the Lp(a) particle is cholesterol-rich, or both. We advise that Lp(a) be measured once, using an isoform-insensitive assay, in subjects at intermediate or high CVD/CHD risk with premature CVD, familial hypercholesterolaemia, a family history of premature CVD and/or elevated Lp(a), recurrent CVD despite statin treatment, ≥3% 10-year risk of fatal CVD according to European guidelines, and/or ≥10% 10-year risk of fatal + non-fatal CHD according to US guidelines. As a secondary priority after LDL-cholesterol reduction, we recommend a desirable level for Lp(a) <80th percentile (less than ∼50 mg/dL). Treatment should primarily be niacin 1–3 g/day, as a meta-analysis of randomized, controlled intervention trials demonstrates reduced CVD by niacin treatment. In extreme cases, LDL-apheresis is efficacious in removing Lp(a). Conclusion We recommend screening for elevated Lp(a) in those at intermediate or high CVD/CHD risk, a desirable level <50 mg/dL as a function of global cardiovascular risk, and use of niacin for Lp(a) and CVD/CHD risk reduction.
|
|
| 7. |
|
|
| 8. |
|
|
